• Je něco špatně v tomto záznamu ?

Cerebrospinal fluid and serum prealbumin (transthyretin) in patients with multiple sclerosis (MS): Comparison of particular subgroups of MS patients

M. Hybeľová, J. Svatoňová, O. Sobek, P. Adam, D. Doležil, D. Adam

. 2009 ; 54 (2) : 173-176.

Jazyk angličtina Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc09002169

The levels of prealbumin (PAB, transthyretin) were determined and evaluated in the cerebrospinal fluid (CSF) and serum in various subgroups of the multiple sclerosis (MS) patients. In severely disabled patients, serum PAB was elevated more frequently. CSF and serum PAB concentrations were higher in treated than in nontreated patients; the values above the upper reference limits were also more frequently found in treated patients. PAB index showed a tendency to decrease during the course of the disease. The routine determination of PAB in CSF and serum is, therefore, recommended to be recognized in MS patients as a substantial clinical value and, thus, be comprised, including also immunoglobulins and other parameters, into the spectrum of characteristics in Protein Panel.

Bibliografie atd.

Lit.: 29

000      
00000naa 2200000 a 4500
001      
bmc09002169
003      
CZ-PrNML
005      
20121210120352.0
008      
091104s2009 xr e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Hybeľová, Mária. $7 xx0274165
245    10
$a Cerebrospinal fluid and serum prealbumin (transthyretin) in patients with multiple sclerosis (MS): Comparison of particular subgroups of MS patients / $c M. Hybeľová, J. Svatoňová, O. Sobek, P. Adam, D. Doležil, D. Adam
314    __
$a Laboratory of Reference for CSF and Neuroimmunology, Department of Clinical Biochemistry, Homolka Hospital, Prague
504    __
$a Lit.: 29
520    9_
$a The levels of prealbumin (PAB, transthyretin) were determined and evaluated in the cerebrospinal fluid (CSF) and serum in various subgroups of the multiple sclerosis (MS) patients. In severely disabled patients, serum PAB was elevated more frequently. CSF and serum PAB concentrations were higher in treated than in nontreated patients; the values above the upper reference limits were also more frequently found in treated patients. PAB index showed a tendency to decrease during the course of the disease. The routine determination of PAB in CSF and serum is, therefore, recommended to be recognized in MS patients as a substantial clinical value and, thus, be comprised, including also immunoglobulins and other parameters, into the spectrum of characteristics in Protein Panel.
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a roztroušená skleróza $x krev $x mok mozkomíšní $x patologie $7 D009103
650    _2
$a prealbumin $x analýza $x mok mozkomíšní $7 D011228
650    _2
$a stupeň závažnosti nemoci $7 D012720
700    1_
$a Svatoňová, Jana $7 xx0111411
700    1_
$a Sobek, Ondřej $7 xx0095947
700    1_
$a Adam, Pavel, $d 1960- $7 nlk19990072987
700    1_
$a Doležil, David, $d 1965- $7 nlk20010102461
700    1_
$a Adam, David $7 xx0116780
773    0_
$w MED00011005 $t Folia microbiologica $g Roč. 54, č. 2 (2009), s. 173-176 $x 0015-5632
910    __
$a ABA008 $b A 2403 $c 561 $y 9
990    __
$a 20091103114455 $b ABA008
991    __
$a 20121210120428 $b ABA008
999    __
$a ok $b bmc $g 691339 $s 553237
BAS    __
$a 3
BMC    __
$a 2009 $b 54 $c 2 $d 173-176 $i 0015-5632 $m Folia microbiologica $x MED00011005
LZP    __
$a 2009-51/ipme

Citační ukazatele

Možnosti archivace